You also want an ePaper? Increase the reach of your titles
YUMPU automatically turns print PDFs into web optimized ePapers that Google loves.
4509 – 4524 – <strong>Wednesday</strong> – Papers/Minisymposium<br />
<strong>Wednesday</strong> Papers/<br />
Minisymposium<br />
11:00 am – 12:45 pm<br />
4509 — 12:15 Long-Term and Lasting<br />
Outcomes of Combination Treatment for<br />
Age-Related Macular Degeneration with<br />
Photodynamic Therapy and Intravitreal<br />
Injection of Anti-Vascular Endothelial Growth<br />
Factor. Colleen M. McLellan, R. Silva-Garcia, K.<br />
W. Small. Molecular Insight Research Foundation,<br />
Glendale, CA *CR<br />
6E<br />
<strong>Wednesday</strong>, May 08, 2013 11:00 AM-12:45 PM<br />
Retina<br />
426 Macular Disease Other<br />
Than AMD II<br />
Moderators: William F. Mieler and<br />
K. Bailey Freund<br />
4510 — 11:00 Occult Central Serous<br />
Chorioretinopathy. K Bailey Freund 1, 2 , D.<br />
Warrow 3 , R. Gallego-Pinazo 1, 5 , Q. V. Hoang 4 .<br />
1<br />
Ophthalmology, Vitreous Retina Macula<br />
Consultants New York, New York, NY;<br />
2<br />
Ophthalmology, New York University, New<br />
York, NY; 3 Ophthamology, New York Eye and<br />
Ear Infirmary, New York, NY; 4 Ophthalmology,<br />
Columbia University, New York, NY;<br />
5<br />
Ophthalmology, University and Polytechnic<br />
Hospital La Fe, Valencia, Spain *CR<br />
4511 — 11:15 Effect of Somatostatin on the<br />
expression of tight junctions and urokinase<br />
plasminogen activator receptor in human retinal<br />
pigment epithelial cells. Alex Fonollosa 1, 2 , J.<br />
Artaraz 1 , A. Martinez-Berriotxoa 1 , E. Vecino 2 .<br />
1<br />
Ophthalmology, Hospital de Cruces, Portugalete,<br />
Spain; 2 Grupo de Oftalmobiologia Experimental,<br />
Bilbao, Spain<br />
4512 — 11:30 Selective Laser Photocoagulation<br />
of Peripheral Non-perfused Retinal Areas<br />
May Improve the Vision in Patients with<br />
Central Retinal Vein Occlusion Treated with<br />
Ranibizumab. Matus Rehak 1 , A. Franke 2 , P. M.<br />
Wiedemann 1 . 1 Department of Ophthalmology,<br />
University of Leipzig, Leipzig, Germany; 2 Clinical<br />
Trial Centre (ZKS) Leipzig, University of Leipzig,<br />
Leipzig, Germany *CR, f<br />
4513 — 11:45 Macular Bruchs Membrane<br />
Defects and Axial Length: Association with<br />
Gamma Zone and Delta Zone in Peripapillary<br />
Region. Jost B. Jonas 1 , K. Ohno-Matsui 2 ,<br />
R. F. Spaide 3 , L. Holbach 4 , S. Panda-Jonas 1 .<br />
1<br />
Ophthalmology, Medical Faculty Mannheim-<br />
Heidelberg, Mannheim, Germany; 2 Department<br />
of Ophthalmology and Visual Science, Tokyo<br />
Medical and Dental University, Tokyo, Japan;<br />
3<br />
Vitreous-Retina-Macula Consultants of New<br />
York and the LuEsther T. Mertz Retinal Research<br />
Center, Manhattan Eye, Ear, and Throat Hospital,<br />
New York, NY; 4 Department of Ophthalmology,<br />
Friedrich-Alexander University Erlangen-Nürnberg,<br />
Erlangen, Germany *CR<br />
4514 — 12:00 Treatment Experience with<br />
Intravitreal Aflibercept Injection (IAI) After<br />
Switching to PRN Dosing in Patients with<br />
Macular Edema Secondary to Central Retinal<br />
Vein Occlusion (CRVO). David M. Brown 1 , F. G.<br />
Holz 2 . 1 Retina Consultants of Houston, Houston,<br />
TX; 2 Department of Ophthalmology, University of<br />
Bonn, Bonn, Germany *CR, f<br />
4515 — 12:15 Two-Year Results of the<br />
COPERNICUS Study Evaluating Intravitreal<br />
Aflibercept Injection (IAI) for Macular Edema<br />
Secondary to Central Retinal Vein Occlusion<br />
(CRVO). W. Lloyd Clark. Palmetto Retina Center,<br />
West Columbia, SC *CR, f<br />
4516 — 12:30 Eighteen-Month Results of<br />
the GALILEO Study Evaluating Intravitreal<br />
Aflibercept Injection (IAI) for Macular Edema<br />
Secondary to Central Retinal Vein Occlusion<br />
(CRVO). Yuichiro Ogura 1 , J. Korobelnik 2 , J.<br />
Roider 3 , R. Vitti 4 , F. G. Holz 5 , F. Hiemeyer 6 , B.<br />
Stemper 6 , O. Zeitz 6 , R. Sandbrink 6 . 1 Department<br />
of Ophthalmology, Nagoya City University<br />
Medical School, Nagoya, Japan; 2 Department<br />
of Ophthalmology, CHU Bordeaux, Universite<br />
Bordeuax, Bordeaux, France; 3 Department of<br />
Ophthalmology, University Medical Center<br />
Schleswig-Holstein, Kiel, Germany; 4 Regeneron<br />
Pharmaceuticals Inc., Tarrytown, NY; 5 Department<br />
of Ophthalmology, University of Bonn, Bonn,<br />
Germany; 6 Bayer Healthcare, Berlin, Germany<br />
*CR, f<br />
606/607<br />
<strong>Wednesday</strong>, May 08, 2013 11:00 AM-12:45 PM<br />
Immunology/Microbiology<br />
427 Ocular Immune Responses<br />
Moderators: Holly L. Rosenzweig and<br />
Thomas Langmann<br />
4517 — 11:00 Loss of MicroRNA-124<br />
and MicroRNA-126 expression regulates<br />
inflammatory microglial activation in inherited<br />
retinal degeneration. Thomas Langmann 1, 2 , C.<br />
Moehle 3 , M. Karlstetter 1 , B. H. Weber 2 . 1 Department<br />
of Ophthalmology, University of Cologne, Cologne,<br />
Germany; 2 Institute of Human Genetics, University<br />
of Regensburg, Regensburg, Germany; 3 Center of<br />
Excellence for Fluorescent Bioanalytics, University<br />
of Regensburg, Regensburg, Germany<br />
4518 — 11:15 Mice lacking TNFR1 develop<br />
less angiogenesis during late stage experimental<br />
autoimmune uveoretinitis (EAU). Madeleine<br />
Stimpson 1 , J. Liu 1 , D. A. Copland 1 , T. K. Khera 1 ,<br />
A. D. Dick 1, 2 . 1 Academic Unit of Ophthalmology,<br />
University of Bristol, Bristol, United Kingdom;<br />
2<br />
Cellular and Molecular Medicine, University of<br />
Bristol, Bristol, United Kingdom *CR<br />
4519 — 11:30 Differential effects of TLR-<br />
3 activated RPE on retinal microglia and<br />
blood-derived monocytes. Alexa K. Klettner 1 ,<br />
T. Hamann 1 , S. Wilker 1 , C. Berg 1 , K. Schlüter 1 , R.<br />
Lucius 2 , M. Rolf 2 , J. Roider 1 . 1 Ophthalmology, Univ<br />
of Kiel, Kiel, Univ Medical Center, Kiel, Germany;<br />
2<br />
Anatomy, University of Kiel, Kiel, Germany *CR<br />
4520 — 11:45 Demonstration of Donor T cell<br />
Recruitment and Correlation with Inflammatory<br />
Cytokine Presence in Experimental Ocular<br />
Graft-versus-Host Disease. Samantha Herretes 1 ,<br />
J. C. Murillo 1 , D. Ross 2 , H. Barreras 2 , Y. Tan 1 , A. M.<br />
Saeed 1 , A. Gonzalez 1 , C. Betancurt 1 , R. B. Levy 2 , V.<br />
L. Perez 1, 2 . 1 Ophthalmology, Bascom Palmer Eye<br />
Inst, Univ of Miami, Miami, FL; 2 Immunology and<br />
Microbiology, University of Miami, Miami, FL *CR<br />
4521 — 12:00 Monophasic PDSAg-induced<br />
EAU dominates over relapsing R14-induced<br />
EAU. Ulrike Kaufmann, M. Diedrichs-Möhring,<br />
G. Wildner. Ophthalmology, Clinic of the Ludwig-<br />
Maximilians-University, Munich, Germany<br />
4522 — 12:15 Inhibition of Vascular<br />
Endothelial Growth Factor Ameliorates Ocular<br />
Allergy in the Murine Model. Daniel R. Saban 1 ,<br />
R. Dana 2 , H. Lee 2 , T. Blanco 1 . 1 Ophthalmology,<br />
Duke University School of Medicine, Durham, NC;<br />
2<br />
Ophthalmology, Schepens Eye Res Inst, Mass. Eye<br />
& Ear, Harvard Medical School, Boston, MA *CR<br />
4523 — 12:30 Translational Modeling of<br />
Calpain-5 Vitreoretinopathy Mechanisms<br />
in Mice. Vinit B. Mahajan 1, 2 , K. J. Wert 3 , J. M.<br />
Skeie 1, 2 , S. H. Tsang 4 . 1 Ophthalmology, University<br />
of Iowa, Iowa City, IA; 2 Omics Laboratory,<br />
University of Iowa, Iowa City, IA; 3 Institute of<br />
Human Nutrition, Columbia University, New York,<br />
NY; 4 Ophthalmology, Columbia University, New<br />
York, NY<br />
608<br />
<strong>Wednesday</strong>, May 08, 2013 11:00 AM-12:45 PM<br />
Anatomy/Pathology<br />
428 Uveal Melanoma: Experimental<br />
Therapeutics<br />
Moderators: Hans Grossniklaus, Sarah E.<br />
Coupland and Arun D. Singh<br />
4524 — 11:00 Microphthalmia-associated<br />
transcription factor (MITF) and Steroid<br />
Receptor Coactivator (SRC)-3 cooperate to<br />
promote proliferation, survival and metabolism<br />
in Gα-mutant uveal melanoma (UM) cells.<br />
Vassiliki Poulaki 1, 2 , S. Chew 3, 4 , B. He 3, 4 , V.<br />
Eedunuri 5 , M. M. Jager 6 , B. W. O’Malley 4 ,<br />
N. Mitsiades 3, 4 . 1 Ophthalmology, Boston VA<br />
Healthcare System, Boston, MA; 2 Ophthalmology,<br />
Boston University, Boston, MA; 3 Medicine,<br />
Baylor College of Medicine, Houston, TX;<br />
4<br />
Molecular and Cellular Biology, Baylor College<br />
of Medicine, Houston, TX; 5 Adrienne Helis Malvin<br />
Medical Research Foundation, New Orleans, LA;<br />
6<br />
Ophthalmology, Leiden University Medical Center,<br />
Leiden, Netherlands<br />
The Commercial Relationships (CR) Index for Disclosures and the Clinical Trial (CT) Registration Index are at arvo.org/2013/ProgramSummary/Index.<br />
294